View clinical trials related to Other Solid Tumours.
Filter by:The purpose of the study is to determine to evaluate safety and tolerability of CPL304110 when administered once daily to adults with advanced solid malignancies.
This is a phase 1/2A, open label, non-randomized study in patients with advanced solid tumours including malignant glioma